LICENSE AGREEMENT by and between Durect Corporation and Gilead Sciences, Inc. dated July 19, 2019License Agreement • November 5th, 2019 • Durect Corp • Pharmaceutical preparations
This LICENSE AGREEMENT (this “Agreement”) is effective as of July 19, 2019 (the “Effective Date”) by and between Durect Corporation, a Delaware company having offices located at 10260 Bubb Road, Cupertino, California 95014 (“Durect”), and Gilead Sciences, Inc., a Delaware corporation having offices located at 333 Lakeside Drive, Foster City, CA 94404 (“Gilead”). Gilead and Durect are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.”
